tiprankstipranks
Rakovina Therapeutics Debentureholders Opt for Shares
Company Announcements

Rakovina Therapeutics Debentureholders Opt for Shares

Story Highlights

Rakovina Therapeutics Inc (TSE:RKV) has released an update.

Pick the best stocks and maximize your portfolio:

Rakovina Therapeutics Inc. has announced that some debenture holders have chosen to receive common shares instead of cash as part of their interest payment, amounting to approximately $20,500. The issuance of these shares is contingent upon the discounted market price and necessary approvals from the TSX Venture Exchange.

For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskRakovina Therapeutics: AI-Driven Success and Financial Growth
TipRanks Canadian Auto-Generated NewsdeskRakovina Therapeutics Closes $3M Funding Round
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App